HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synthesis, physicochemical properties, anticonvulsant activities and voltage-sensitive calcium channels affinity of N-substituted amides of alpha-(4-phenylpiperazino)-GABA. Part 3: Search for new anticonvulsant compounds.

Abstract
This paper describes the synthesis and preliminary anticonvulsant evaluation of some GABA analogues i.e. derivatives of 2-(4-phenylpiperazino)- or 2-(4-benzylpiperidino)-GABA (5, 6), N-substituted amides of 2-(4-phenylpiperazino)-4-phthalimidobutyric acid and N-substituted amides of 2-(4-phenylpiperazino)-GABA. N-Substituted amides of 2-(4-phenylpiperazino)-4-phthalimidobutyric acid (7-11) were prepared by condensation of the acid with the corresponding derivatives of benzylamine in the presence of different coupling reagents (2-chloro-4,6-dimethoxy-1,3,5-triazine (CDMT) and carbonyldiimidazole (CDI). N-Substituted benzylamides of 2-(4-phenylpiperazino)-4-aminobutyric acid (12-14) were prepared by hydrazinolysis of amides 9-11. Anticonvulsant activities were determined in mice (for all compounds) and in rats using the subcutaneous metrazol (scMet) and maximal electroshock (MES) screens. The amides (12-14) showed protection against MES and/or scMet seizures in mice. N-(4-Methoxybenzyl)-2-(4-phenylpiperazin-1-yl)-4-aminobutyric amide (13) was the most effective and displayed anticonvulsant activity in both tests at doses of 100-300 mg/kg in mice and at 30 mg/kg in the MES screen in rats. The active compounds (12-14) were tested for their ability to displace [3H]nitrendipine binding sites (voltage-sensitive calcium channel receptors) from rat cortex. Amide 13 was the most active both in pharmacological and biochemical tests. These preliminary results suggest that the anticonvulsant activity of compounds 12-14 may be related to their influence on voltage-sensitive calcium channel receptors.
AuthorsB Malawska, L Antkiewicz-Michaluk
JournalDie Pharmazie (Pharmazie) Vol. 54 Issue 4 Pg. 239-43 (Apr 1999) ISSN: 0031-7144 [Print] Germany
PMID10234733 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Aminobutyrates
  • Anticonvulsants
  • Calcium Channel Blockers
  • Calcium Channels
  • N-(4-fluorobenzyl)-2-(4-phenylpiperazin-1-yl)-4-aminobutyric amide
  • N-(4-methoxybenzyl)-2-(4-phenylpiperazin-1-yl)-4-aminobutyric amide
  • N-benzyl-2-(4-phenylpiperazin-1-yl)-4-aminobutyric amide
  • Piperazines
  • Nitrendipine
Topics
  • Aminobutyrates (chemical synthesis, pharmacology)
  • Animals
  • Anticonvulsants (chemical synthesis, pharmacology)
  • Binding, Competitive
  • Calcium Channel Blockers (metabolism)
  • Calcium Channels (drug effects, metabolism)
  • Cerebral Cortex (drug effects, metabolism)
  • In Vitro Techniques
  • Ion Channel Gating
  • Mice
  • Nitrendipine (metabolism)
  • Piperazines (chemical synthesis, pharmacology)
  • Radioligand Assay
  • Rats

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: